PLOS One published a correction clarifying the corresponding author for a previously published research article that examines the relationship between the triglyceride-glucose index and the neutrophil-to-lymphocyte ratio in patients with T2DM who experienced STEMI and underwent primary PCI. The notice addresses an authorship metadata error; it does not change any reported study data or outcomes.
The correction specifies that Jingyan Yang was incorrectly listed as the corresponding author in the original article. The correct corresponding author is Juan Zhang. The publisher explicitly apologized for the error. Changing the designated corresponding author affects the official point of contact for follow-up questions, data requests, and formal communications about the paper. Investigators reported the correction solely as an authorship and contact update; no modifications to the manuscript body, figures, tables, or results were indicated in the correction notice.
Designating the accurate corresponding author ensures that readers and other researchers reach the right individual for clarifications. That matters for requests about data availability statements, clarifying analytic approaches, or arranging material transfers—activities commonly routed through the corresponding author. The correction notice did not describe any procedural reasons for the initial misattribution.
The correction itself is indexed and citable. The PLOS One Staff is listed as the author of the correction. The correction citation is: PLoS One 21(10): e0361392, DOI https://doi.org/10.1371/journal.pone.0361392, published October 23, 2026. The original article is cited within the correction as: Yang J, Xu D, Liu X, Zhao Z, Zhang J. The triglyceride-glucose index and neutrophil-to-lymphocyte ratio jointly predict the no-reflow phenomenon in T2DM patients with STEMI after primary PCI. PLoS One. 2026;21(3):e0345466. The correction also records the original article’s PubMed identifier: pmid:41860875.
This metadata provides the formal trail for bibliographic databases and for anyone updating institutional repositories, citation managers, or literature reviews to ensure accurate author contact information.
The correction supplies the correct email for the corresponding author: Juan Zhang at awwa6940@sina.com. That address is now the official channel for inquiries related to the original article. The correction does not provide additional contact details such as phone number, institution, or alternate emails.
Readers should use Juan Zhang’s email for requests that typically pass through corresponding authorship: data access clarifications, questions about analytic code or outputs if available, or permissions concerning material reuse beyond the scope of the published license. The correction does not indicate any changes in authorship order or author contributions beyond the corresponding author designation.
The publisher reiterated that the content is open access under the Creative Commons Attribution License. The correction notice states that the work may be reused, distributed, and reproduced in any medium so long as the original author and source are credited. The correction itself is likewise distributed under the same terms.
This licensing detail matters for clinicians, researchers, and educators who may wish to reproduce figures, tables, or methodology sections in derivative works or educational materials; they must provide proper attribution to the original authors and the PLOS One source as required by the license.
The correction notice is narrowly scoped to authorship metadata and contact information. It does not present new experimental results, methodological clarifications, statistical reanalyses, or corrections to the scientific content of the original manuscript. The publisher did not report reasons for the initial misattribution, nor did the notice describe any changes to author order or contributions beyond the corresponding author role.
For readers seeking further clarification about study details, data, or methods, the corrected corresponding author’s email is provided as the route for inquiry. Any follow-up that pertains to study findings must be directed to Juan Zhang; the correction itself contains no additional substantive content regarding the study’s clinical or analytic claims.